301 related articles for article (PubMed ID: 15024346)
1. Considerations for targeting malignant stem cells in leukemia.
Guzman ML; Jordan CT
Cancer Control; 2004; 11(2):97-104. PubMed ID: 15024346
[TBL] [Abstract][Full Text] [Related]
2. Selective elimination of leukemia stem cells: hitting a moving target.
Crews LA; Jamieson CH
Cancer Lett; 2013 Sep; 338(1):15-22. PubMed ID: 22906415
[TBL] [Abstract][Full Text] [Related]
3. Right on target: eradicating leukemic stem cells.
Krause DS; Van Etten RA
Trends Mol Med; 2007 Nov; 13(11):470-81. PubMed ID: 17981087
[TBL] [Abstract][Full Text] [Related]
4. CBP/Catenin antagonists: Targeting LSCs' Achilles heel.
Kim YM; Gang EJ; Kahn M
Exp Hematol; 2017 Aug; 52():1-11. PubMed ID: 28479420
[TBL] [Abstract][Full Text] [Related]
5. Targeting the bone marrow microenvironment in acute leukemia.
Karantanou C; Godavarthy PS; Krause DS
Leuk Lymphoma; 2018 Nov; 59(11):2535-2545. PubMed ID: 29431560
[TBL] [Abstract][Full Text] [Related]
6. Cancer Stem Cells in the Development of Novel Therapeutics for Refractory Pediatric Leukemia.
Brennan L; Narendran A
Stem Cells Dev; 2019 Oct; 28(19):1277-1287. PubMed ID: 31364487
[TBL] [Abstract][Full Text] [Related]
7. Chronic myeloid leukemia stem cells.
Kavalerchik E; Goff D; Jamieson CH
J Clin Oncol; 2008 Jun; 26(17):2911-5. PubMed ID: 18539972
[TBL] [Abstract][Full Text] [Related]
8. beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia.
Hu Y; Chen Y; Douglas L; Li S
Leukemia; 2009 Jan; 23(1):109-16. PubMed ID: 18818703
[TBL] [Abstract][Full Text] [Related]
9. TIM-3 as a therapeutic target for malignant stem cells in acute myelogenous leukemia.
Kikushige Y; Akashi K
Ann N Y Acad Sci; 2012 Aug; 1266():118-23. PubMed ID: 22901263
[TBL] [Abstract][Full Text] [Related]
10. [Progress in the studies of acute myelogenous leukemia stem cell].
Cui JW; Zhang XM; Wang GJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Oct; 11(5):549-52. PubMed ID: 14575558
[TBL] [Abstract][Full Text] [Related]
11. Targeting the leukemic stem cell: the Holy Grail of leukemia therapy.
Misaghian N; Ligresti G; Steelman LS; Bertrand FE; Bäsecke J; Libra M; Nicoletti F; Stivala F; Milella M; Tafuri A; Cervello M; Martelli AM; McCubrey JA
Leukemia; 2009 Jan; 23(1):25-42. PubMed ID: 18800146
[TBL] [Abstract][Full Text] [Related]
12. Amide-linked local anesthetics preferentially target leukemia stem cell through inhibition of Wnt/β-catenin.
Ni J; Xie T; Xiao M; Xiang W; Wang L
Biochem Biophys Res Commun; 2018 Sep; 503(2):956-962. PubMed ID: 29932919
[TBL] [Abstract][Full Text] [Related]
13. Leukemia stem cells: the root of chronic myeloid leukemia.
Zhou H; Xu R
Protein Cell; 2015 Jun; 6(6):403-12. PubMed ID: 25749979
[TBL] [Abstract][Full Text] [Related]
14. Leukemic Stem Cells: From Leukemic Niche Biology to Treatment Opportunities.
Marchand T; Pinho S
Front Immunol; 2021; 12():775128. PubMed ID: 34721441
[TBL] [Abstract][Full Text] [Related]
15. Concise Review: Exploiting Unique Biological Features of Leukemia Stem Cells for Therapeutic Benefit.
Zhang H; Li S
Stem Cells Transl Med; 2019 Aug; 8(8):768-774. PubMed ID: 31016860
[TBL] [Abstract][Full Text] [Related]
16. Leukemia stem cells.
Buss EC; Ho AD
Int J Cancer; 2011 Nov; 129(10):2328-36. PubMed ID: 21796620
[TBL] [Abstract][Full Text] [Related]
17. Transmembrane TNF-α preferentially expressed by leukemia stem cells and blasts is a potent target for antibody therapy.
Zhou X; Zhou S; Li B; Li Q; Gao L; Li D; Gong Q; Zhu L; Wang J; Wang N; Huang L; Zhao L; Li Z; Zhou J
Blood; 2015 Sep; 126(12):1433-42. PubMed ID: 26224647
[TBL] [Abstract][Full Text] [Related]
18. Cellular and Molecular State of Myeloid Leukemia Stem Cells.
Xie X; Feng M; Wang Q; Wang J; Yin R; Li Y; Zhang H
Adv Exp Med Biol; 2019; 1143():41-57. PubMed ID: 31338814
[TBL] [Abstract][Full Text] [Related]
19. CD150(-) Side Population Defines Leukemia Stem Cells in a BALB/c Mouse Model of CML and Is Depleted by Genetic Loss of SIRT1.
Wang Z; Chen CC; Chen W
Stem Cells; 2015 Dec; 33(12):3437-51. PubMed ID: 26466808
[TBL] [Abstract][Full Text] [Related]
20. Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8).
Guzman ML; Li X; Corbett CA; Rossi RM; Bushnell T; Liesveld JL; Hébert J; Young F; Jordan CT
Blood; 2007 Dec; 110(13):4436-44. PubMed ID: 17785584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
